Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-15-035898
Filing Date
2015-06-08
Accepted
2015-06-08 06:08:24
Documents
2
Period of Report
2015-06-08

Document Format Files

Seq Description Document Type Size
1 6-K v412639_6k.htm 6-K 52674
2 GRAPHIC tlogo.jpg GRAPHIC 8186
  Complete submission text file 0001144204-15-035898.txt   65100
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 15917310
SIC: 2834 Pharmaceutical Preparations